AlveoGene
The startup develops a gene therapy that delivers treatment for respiratory diseases via a nebulizer, effectively transducing lung epithelial cells to enhance therapeutic efficacy. This method provides a prolonged duration of action, enabling patients to experience significant improvements in lung function.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$3.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
OS
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a gene therapy that delivers treatment for respiratory diseases via a nebulizer, effectively transducing lung epithelial cells to enhance therapeutic efficacy. This method provides a prolonged duration of action, enabling patients to experience significant improvements in lung function.